Loureiro P A, Correia J M
Rev Port Cardiol. 1989 Nov;8(11):775-8.
To evaluate efficacy of the association furosemide-metolazona in ten retrospective cases of Congestive heart failure, furosemide resistant.
Service of cardiology, patients admitted in two year period, from September 1985 through May 1987.
Revision of ten cases of congestive heart failure who was administered metolazona after inadequate response to furosemide. The etiology of congestive heart failure included three cases of ischemic heart disease, two cases of dilated myocardiopathy, two cases of rheumatic valvular cardiopathy, one case of congenital heart disease, two cases with no established etiology. All cases was in functional class III and IV of NYHA classification.
Good results were obtained in eight patients. The other two were not different in etiology of heart failure, renal function, serum electrolytics and associated therapy. Diuresis was independent of the creatinine plasmatic values.
In our study, in eight of ten cases, metolazona had additive diuretic effect when associated to furosemide in patients with congestive heart failure.
评估速尿-美托拉宗联合用药对十例难治性充血性心力衰竭患者的疗效。
心脏病科,1985年9月至1987年5月两年期间收治的患者。
回顾十例充血性心力衰竭患者,这些患者在对速尿反应不佳后使用了美托拉宗。充血性心力衰竭的病因包括三例缺血性心脏病、两例扩张型心肌病、两例风湿性瓣膜性心脏病、一例先天性心脏病、两例病因不明。所有病例均处于纽约心脏病协会(NYHA)心功能分级的III级和IV级。
八名患者取得了良好效果。另外两名患者在心力衰竭病因、肾功能、血清电解质及相关治疗方面并无差异。利尿作用与血浆肌酐值无关。
在我们的研究中,十例患者中有八例,美托拉宗与速尿联合应用于充血性心力衰竭患者时具有附加利尿作用。